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Aortic Valve Replacement for Aortic Stenosis and Concomitant 
Coronary Artery Bypass: Long-term Outcomes and 
Predictors of Mortality
Won-Chul  Cho,  M.D.*,  Dong-Gon  Yoo,  M.D.**,  Joon-Bum  Kim,  M.D.*, J a e - W o n  L e e ,  M . D . * ,  
Suk-Jung  Choo,  M.D.*,  Sung-Ho  Jung,  M.D.*,  Cheol-Hyun  Chung,  M.D.*
Background:  We evaluated the surgical results and predictors of long-term survival in patients who underwent cor-
onary artery bypass grafting (CABG) at the time of an aortic valve replacement (AVR) due to aortic stenosis. 
Materials and Methods: Between January 1990 and December 2009, 183 consecutive patients underwent CABG 
and concomitant aortic valve replacement for aortic stenosis. The mean follow-up period was 59.8±3.3 months and 
follow-up was possible in 98.3% of cases. Predictors of mortality were determined by Cox regression analysis. 
Results: There were 5 (2.7%) in-hospital deaths. Follow-up of the in-hospital survivors documented late survival rates 
of 91.5%, 74.8%, and 59.6% at 1, 5, and 10 postoperative years, respectively. Age (p＜0.001), a glomerular filtra-
tion rate (GFR) less than 60 mL/min (p=0.006), and left ventricular (LV) mass (p＜0.001) were significant pre-
dictors of mortality in the multivariate analysis. Conclusion: The surgical results and long-term survival of aortic 
valve replacement with concomitant CABG in patients with aortic stenosis and coronary artery disease were 
acceptable. Age, a GFR less than 60 mL/min, and LV mass were significant predictors of mortality.
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INTRODUCTION
Aortic  stenosis  and  coronary  atherosclerosis  can  indepen-
dently  cause  myocardial  ischemia  and  the  sequelae  of  my-
ocardial ischemia including angina, myocardial infarction, and 
d e a t h .  A  r e v i e w  o f  t h e  r e s u l t s   of  combined  aortic  valve  re-
placement (AVR) and coronary artery bypass grafting (CABG) 
in  several  centers  shows  more  variable  mortality  than  that 
seen  after  isolated  aortic  valve  replacement  [1-6].  Therefore, 
the  present  study  analyzed  the  surgical  results  and  predictors 
of  long-term  survival  in  patients  who  underwent  combined 
AVR  and  CABG  for  aortic  stenosis  and  coronary  artery 
disease.
MATERIALS AND METHODS
1) Patients
    The  present  study  examined  the  records  of  183  patients 
who underwent combined AVR and CABG for aortic stenosis 
and  co-existing  coronary  artery  disease  at  our  institution  be-Won-Chul Cho, et al
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tween  January  1990  and  December  2009.  Data  collection  in-
volved  reviewing  in-patient  and  out-patient  medical  records, 
and  conducting  telephone  interviews.  The  study  protocol  was 
approved  by  the  Institutional  Review  Board  of  the  Asan 
Medical  Center,  Seoul,  Korea.  The  requirement  for  informed 
patient  consent  was  waived  by  the  board  because  of  the  ret-
rospective  nature  of  the  study.
2) Definitions
    All  patients  underwent  preoperative  cardiac  catheterization 
and  echocardiography  within  2  months  prior  to  surgery. 
Coronary arteries with greater than 70% narrowing were con-
sidered  significantly  stenosed.  Categorization  of  the  extent  of 
coronary  artery  disease  (CAD)  (one-,  two-,  or  three-vessel 
disease)  was  based  on  the  significant  stenosis  of  major  ar-
teries  (left  anterior  descending,  left  circumflex,  or  the  right 
coronary  artery)  or  branches  thereof.  Revascularization  was 
considered  incomplete  if  any  major  artery  or  one  of  the 
branches had a significant stenosis that was not revascularized 
with  a  bypass  graft  at  the  time  of  surgery.  The  severity  of 
aortic  stenosis  was  defined  as  mild,  moderate,  or  severe  by 
using  the  ACC/AHA  guidelines  for  the  management  of  pa-
tients  with  valvular  heart  disease  [7].  Glomerular  filtration 
rate  (GFR)  means  the  estimated  GFR  in  this  study  [8]. 
    Operative  variables  included  completeness  of  myocardial 
revascularization,  type  of  aortic  prosthesis  implanted,  global 
ischemic time, total cardiopulmonary bypass time, and use of 
the internal thoracic artery. The selection of aortic valve pros-
thesis  type  was  based  on  surgeon  and  patient  preference. 
Operative mortality was defined as death prior to discharge or 
any  death  within  30  days  following  surgery.  Major  adverse 
cardiac events (MACE) included anticoagulation complication, 
thrombo-embolism  including  cerebrovascular  attack,  re-inter-
v e n t i o n s  f o r  a o r t i c  v a l v e  o r  c o r o n a r y  a r t e r y ,  a n d  i n f e c t i v e  
endocarditis.
3) Statistical analysis
    Categorical  variables  were  presented  as  frequencies  and 
percentages,  and  were  compared u s i n g  t h e  c h i - s q u a r e  t e s t  o r  
Fisher’s  exact  test.  Continuous  variables  were  expressed  as 
mean±S D  o r  m e d i a n s  w i t h  r a n g e s ,   and  were  compared  using 
the  Student’s  unpaired  t  test  or  Mann-Whitney  U  test,  as 
appropriate.  Kaplan-Meier  curves  were  employed  to  delineate 
overall survival,  and  log-rank  tests were used to  compare  the 
differences in survival rates between groups. Stratified surviv-
a l  c u r v e s  w e r e  p l o t t e d  t o  e x p l ore  unadjusted  differences  for 
variables  of  interest.  For  multivariate  analyses,  updated  co-
variate  Cox’s  proportional  hazard  regression  models  were 
used  to  examine  the  association  of  baseline  characteristics 
with time to death. Variables with a probability value ＜0.05 
in  univariate  analyses  were  candidates  for  the  multivariable 
Cox models. Multivariate analyses involved a backward elim-
ination technique and only variables with a p-value of ＜0.05 
were used in the final model. Results were expressed as haz-
ard  ratios  (HR)  with  95%  confidence  intervals  (CI).  All  re-
ported  p-values  are  two-sided,  and  p-values  of  less  than  0.05 
were  considered  to  indicate  statistical  significance.  SPSS  ver-
s i o n  1 4 . 0  w a s  u s e d  f o r  t h e  s t a t i s t i c a l  a n a l y s i s .
RESULTS
1) Preoperative clinical characteristics and operative 
variables
    The mean age at surgery was 68.0±8.8 years and 60.7% of 
patients were male. Clinical follow up was complete in 98.4% 
of  patients,  with  a  mean  follow-up  duration  of  59.8±3.3 
months.  The  clinical  details  and  results  of  cardiac  catheter-
ization  and  echocadiography  ar e  s h o w n  i n  T a b l e  1 .  M e a n  
cross-clamp  time  and  cardiopulmonary  bypass  time  were 
104.3±42.5  minutes  and  170.1±63  minutes,  respectively.  A 
total  of  103  bioprostheses  (56.3%)  and  80  mechanical  pros-
theses  (43.7%)  were  used.  Overall,  65%  (n=119)  of  patients 
used an internal mammary artery  graft.  Among all  of the  pa-
tients in our study cohort were 40 (21.9%) patients who were 
considered  incompletely  revascularized.  For  all  patients,  the 
reason  for  incomplete  revascularization  was  poor  distal  target 
or  quality.
2) Early outcomes
    Significant postoperative morbidities occurred in 24 patients 
(Table  2).  There  were  five  cases  of  stroke  and  four  cases  of 
bleeding.  Five  (2.7%)  in-hospital  deaths  occurred.  Three  pa-
tients  died  in  the  immediate  postoperative  period,  and  of 
these,  two  deaths  occurred  from  low  cardiac  output  and  the Aortic Valve Replacement and Concomitant Coronary Artery Bypass
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Table 2. Mortality and significant postoperative morbidities
  N u m b e r  ( % )
  Significant  postoperative  morbidities
 S t r o k e  5  ( 2 . 7 )
 C o n g e s t i v e  h e a r t  f a i l u r e  2  ( 1 . 1 )
 P n e u m o n i a  3  ( 1 . 6 )
  Renal  failure  (requiring  dialysis)   3  (1.6)
 B l e e d i n g  4  ( 2 . 2 )
 O t h e r s  7  ( 3 . 8 )
  Mortality
  Operative  mortality   5  (2.7)
  Late  mortality 48  (26.2)
Values  in  parentheses  are  percentages.
Table 1. Preoperative clinical characteristics
          V a r i a b l e N u m b e r  ( % )
Mean  age  (years) 68.0±8.8
Male 111  (60.7)
Preoperative
    NYHA  III   79  (43.2)
    NYHA  IV   12  (6.6)
    Diabetes   52  (28.4)
    Hypertension   96  (52.5)
    Hypercholesterolemia   50  (27.3)
    Angina 104  (56.8)
  C O P D  1 8  ( 9 . 8 )
  H x  o f  M I  1 8  ( 9 . 8 )
    Smoking   72  (39.3)
    A-fib   14  (7.7)
  e G F R  ＜60   51  (27.9)
CAD
    1  Territory   69  (37.7)
    2  Territories   63  (34.4)
    3  Territories   51  (27.9)
Severity  of  aortic  stenosis
  M i l d   0
    Moderate   19  (10.4)
    Severe 164  (89.6)
Values  represent  mean±SD.  Values  in  parentheses  are  percen-
tages.  NYHA=New  York  Heart  Association  functional  class; 
COPD=Chronic  obstructive  pulmonary  disease;  Hx=History; 
MI=Myocardial  infarction;  A-fib=Atrial  fibrillation;  eGFR=Esti-
mated  glomerular  filtration  rate;  CAD=Coronary  artery  disease.
Fig. 1. Long-term survival rate.
Fig. 2. Freedom from Major adverse cardiac events (MACE) and 
mortality.
other was secondary to a hemorrhagic diathesis and complica-
tions.  The  remaining  two  deaths  were  attributable  to  sepsis 
and  postoperative  atrioventricular  block,  respectively. 
3) Late outcomes
  Late death occurred in 48 patients including 31 cardiac and 
17  non-cardiac  deaths.  Non-cardiac  deaths  included  cancer  in 
3  patients,  infection  in  3  patien t s ,  m u lt i o r g a n  f a i lu r e  i n  3  p a -
tients,  and  accidents  and  other  causes  in  6  patients.  Overall 
survival was 91.5±2.1% at 1 year, 74.8±3.6% at 5 years, and 
59.6±5.7%  at  10  years  (Fig.  1). 
    Three  reoperations  were  performed.  One  patient  underwent 
a  redo-CABG  because  of  the  occlusion  of  a  saphenous  vein 
graft  to  the  left  anterior  descending  artery  (LAD).  The  other 
two patients underwent redo-AVR because of prosthetic aortic 
valve  failure  (Fig.  2).
    Univariate  analysis  identified  older  age,  a  GFR  less  than Won-Chul Cho, et al
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Table 4. Univariate and multivariate analysis for risk factors of major adverse cardiac events and mortality
Univariate  analysis Multivariate  analysis
Hazard  ratio  p-value Hazard  ratio  (CI) p-value
NYHA  IV
eGFR  ＜60
Echocardiography  data
    LV  mass  ＞280  g
  L V I D s
  A o r t i c  j e t  v e l o c i t y
    Mean  gradient
  E S V
  E D V
  L V  E F  
Incomplete  revascularization
3.28
3.155
2.28
1.029
0.991
0.987
1.004
1.005
0.982
1.836
0.004
＜0.001
0.009
0.075
0.085
0.1
0.02
0.019
0.06
0.083
 
3.551  (1.964∼6.420)
1.960  (1.008∼3.814)
 
1.005  (1.000∼1.010)
 
  
 
＜0.001
0.047
 
0.049
 
 
Cox  proportional  hazard  model  (backward  LR).  CI=Confidence  interval;  eGFR=Estimated  glomerular  filtration  rate;  AMI=Acute  my-
ocardial  infarction;  NYHA  IV=New  York  Heart  Association  functional  class  IV;  LV=Left  ventricle;  LVIDs=Systolic  left  ventricular 
internal  diameter;  ESV=End-systolic  volume;  EDV=End-diastolic  volume;  EF=Ejection  fraction.
Table 3. Univariate and multivariate analysis for risk factors of mortality
Univariate  analysis Multivariate  analysis
Hazard  ratio  p-value Hazard  ratio  (CI) p-value
Age   
eGFR  ＜60
History  of  AMI
COPD
Bioprosthetic  valve
Echocardiography  data
    LV  mass  ＞280  g
  L V I D s
  E S V
  E D V
  L V  E F  
Incomplete  revascularization
1.083
3.032
2.672
4.079
1.817
1.729
1.029
1.005
1.004
0.977
1.575
＜0.001
＜0.001
0.008
＜0.001
0.055
0.08
0.039
0.023
0.057
0.016
0.229
1.081  (1.034∼1.130)
2.307  (1.222∼4.215)
 
2.176  (1.021∼4.634)
 
 
1.040  (1.009∼1.073)
 
 
  
0.001
0.007
 
0.044
 
 
0.012
 
 
 
Cox  proportional  hazard  model  (backward  LR).  AMI=Acute  myocardial  infarction;  CI=Confidence  Interval;  eGFR=Estimated  glomer-
ular  filtration  rate;  AMI=Acute  myocardial  infarction;  NYHA  IV=New  York  Heart  Association  functional  class  IV;  LV=Left  ven-
tricle;  LVIDs=Systolic  left  ventricular  internal  diameter;  ESV=End-systolic  volume;  EDV=End-diastolic  volume;  EF=Ejection  fraction.
60 mL/min, history of myocardial infarction (MI), presence of 
chronic  obstructive  pulmonary  disease  (COPD),  left  ven-
tricular  internal  dimension  of  systole  (LVIDs),  end-systolic 
volume  (ESV)  and  lower  ejection  fraction  as  factors  asso-
ciated  with  overall  mortality.  Multivariate  analysis  revealed 
that older age, a GFR less than 60 mL/min, and LVIDs were 
independent  factors  affecting  long-term  survival  (Table  3).
  In terms of MACE and death, univariate analysis identified 
a  GFR  less  than  60  mL/min,  New  York  Heart  Association 
class  IV,  echocardiographic  data  including  LV  mass  greater 
t h a n  2 8 0  g ,  E S V ,  a n d  E D V  a s  s i g n i f i c a n t  f a c t o r s .  M u l t i v a -
riate  analysis  revealed  that  a  GFR  less  than  60  mL/min, 
EDV, and LV mass greater than 280 g were also independent 
factors  in  MACE  and  death  (Table  4).
DISCUSSION
    The present study  examined surgical and long-term clinical Aortic Valve Replacement and Concomitant Coronary Artery Bypass
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outcomes  following  combined  AVR  and  CABG  in  patients 
with  aortic  stenosis  and  coronary  artery  disease.  The  out-
comes and survival rates were acceptable. The operative mor-
tality  rate  was  2.7%.  This  rate  was  similar  to  rates  reported 
by  others,  which  ranged  from  3.4%  to  6.5%  [2,9-13],  and 
which  were  no  different  from  those  for  patients  undergoing 
isolated  AVR  and  not  CABG  [14-16].  In  the  current  study, 
the  10-year  cumulative  survival  rate  was  59.6%,  which  was 
similar  to  rates  reported  by  others  (52%  in  [10]  and  55%  in 
[9,11]). 
    The  present  study  included  18  patients  (10.8%)  with  mod-
erate  aortic  stenosis.  It  is  broadly  accepted  that  AVR  should 
be  performed  in  conjunction  with  CABG  if  aortic  stenosis  is 
severe  or  if  the  patient  has  symptoms.  However,  controversy 
exists  regarding  the  treatment  of  asymptomatic  patients  with 
mild  or  moderate  stenosis  [17,18].  A  recent  study  showed 
that  AVR  at  the  time  of  CABG  for  mild  or  moderate  aortic 
stenosis  appeared  to  convey  a  survival  advantage  on  patients 
with moderate aortic stenosis but not on those with mild aort-
ic  stenosis  [11,19,20].
1) Risk factors for long-term clinical outcomes
    The  present  study  found  that  older  age  had  a  negative  ef-
fect  on  long-term  survival,  as  reported  elsewhere  [3,10,12]. 
We found that in patients ≥70 years old, the 10-year surviv-
al  rate  was  24.5±10.7%,  and  that  the  rate  decreased  with 
greater  age.  This  shorter  life  expectancy  for  patients  older 
than 70 years should be taken into account when considering 
surgery  in  such  patients.
    We  found  that  incomplete  CABG  revascularization  did  not 
influence late survival. An early study by Kobayashi and col-
leagues  [21]  showed  that  although  extensive  CAD  negatively 
influenced  early  mortality,  this  did  not  negatively  affect  late 
survival.  In  addition,  the  number  of  diseased  territories,  the 
number  of  bypass  grafts,  incomplete  revascularization,  aortic 
stenosis, and aortic insufficiency did not predict late mortality 
in  the  cited  study  or  our  present  work.
    The  present  study  found  that  survival  was  not  affected  by 
valve  type  (mechanical  or  bioprosthetic).  These  findings  are 
consistent  with  previous  studies  showing  satisfactory  long- 
term results using either mechanical or bioprosthetic valves in 
AVR  [22,23]  and  AVR-CABG  [24,25]  patients. 
  L V  m a s s  i s  p r o p o r t i o n a l  t o  t h e  t o t a l  f o r c e  t h a t  c o n t r a c t i n g  
LV  walls  must  receive  at  end-systole.  As  aortic  stenosis  be-
comes  more  severe,  the  measured  values  of  LV  mass,  EDV, 
and  LVID  also  become  greater.  These  changes  in  the  meas-
ured  value  mean  LV  hypertrophy  (LVH).  The  results  of  the 
present  study  found  that  preoperative  LVH  might  be  a  neg-
ative effect of both mortality and MACE, including mortality, 
because  LVH  caused  problems  with  myocardial  protection 
and  remodeling  due  to  scar  change.  Early  surgery  might 
therefore  be  a  therapeutic  option  to  further  improve  clinical 
outcomes  and  lessen  operative  risk  [26,27].
    The  analysis  of  left  ventricular  function  and  its  influence 
on  long-term  survival  is  complex  in  patients  with  both  aortic 
valve  disease  and  coronary  disease.  Segmental  dysfunction 
secondary  to  myocardial  infarction  will  not  be  improved  by 
surgery and may theoretically have a more profound effect on 
risk than will generalized impairment of left ventricular func-
tion caused by aortic stenosis [9]. Previous studies [10,12,21] 
showed that a low EF increased the risk of undergoing AVR- 
CABG.  However,  EF  was  not  found  to  influence  long-term 
survival  in  the  current  study.
    Several  studies  have  documented  ten-year  cumulative  sur-
vival  rates  similar  (52%  [10],  55%  [9,11])  to  the  59%  from 
this study. Although this study contains younger patients with 
higher  preoperative ejection  fractions,  several  factors  were  al-
so  identified  in  this  study  as  significant  predictors  of  morta-
lity.
CONCLUSION
    The  surgical  results  and  long-term  survival  rates  were  ac-
ceptable for patients undergoing a combined CABG for aortic 
stenosis  and  coronary  artery  disease.  Multivariate  analysis 
found that older age, a GFR less than 60 mL/min, and great-
er LVIDs were independent variables affecting long-term sur-
vival  in  such  patients.
REFERENCES
1. Varadarajan  P,  Kapoor  N,  Bansal  RC,  Pai  RG.  Survival  in 
elderly  patients  with  severe  aortic  stenosis  is  dramatically 
improved by aortic valve replacement: results from a cohort 
of  277  patients  aged  ＞ or  =80  years.  Eur  J  Cardiothorac Won-Chul Cho, et al
− 136  −
Surg  2006;30:722-7.
2. Richardson  JV,  Kouchoukos  NT,  Wright  JO,  Karp  RB. 
Combined  aortic  valve  replacement  and  myocardial  revas-
cularization:  results  in  220  patients.  Circulation  1979;59:75- 
81.
3. He GW, Grunkemeier GL, Starr A. Aortic valve replacement 
i n  e l d e r l y  p a t i e n t s :  i n f l u e n c e   of  concomitant  coronary  graft-
ing  on  late  survival.  Ann  Thorac  Surg  1996;61:1746-51.
4. Grimard  BH,  Larson  JM.  Aortic  stenosis:  diagnosis  and 
treatment.  Am  Fam  Physician  2008;78:717-24.
5. Tjang  YS,  van  Hees  Y,  Korfer  R,  Grobbee  DE,  van  der 
Heijden  GJ.  Predictors  of  mortality  after  aortic  valve  re-
placement.  Eur  J  Cardiothorac  Surg  2007;32:469-74.
6 . J o n e s  M ,  S c h o f i e l d  P M ,  B r o o k s  N H ,  e t  a l .  A o r t i c  v a l v e  r e -
placement  with  combined  myocardial  revascularisation.  Br 
Heart  J  1989;62:9-15.
7. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused 
update  incorporated  into  the  ACC/AHA  2006  guidelines  for 
the  management  of  patients  with  valvular  heart  disease:  a 
report  of  the  American  College  of  Cardiology/American 
Heart  Association  Task  Force  on  Practice  Guidelines 
(Writing  Committee  to  revise  the  1998  guidelines  for  the 
management  of  patients  with  valvular  heart  disease). 
Endorsed by the Society of Cardiovascular Anesthesiologists, 
Society  for  Cardiovascular  Angiography  and  Interventions, 
and  Society  of Thoracic  Surgeons. J Am Coll  Cardiol  2008; 
52:e1-142.
8 . J i n  R ,  G r u n k e m e i e r  G L ,  B r o w n  J R ,  F u r n a r y  A P .  Estimated 
glomerular  filtration  rate  and  renal  function.  Ann  Thorac 
Surg  2008;86:1-3.
9. Lytle  BW,  Cosgrove  DM,  Loop  FD,  et  al.  Replacement  of 
aortic valve combined with myocardial revascularization: de-
terminants  of  early  and  late  risk  for  500  patients,  1967- 
1981.  Circulation  1983;68:1149-62.
10. Lytle  BW,  Cosgrove  DM,  Goormastic  M,  Loop  FD.  Aortic 
valve  replacement  and  coronary  bypass  grafting  for  patients 
with  aortic  stenosis  and  coronary  artery  disease:  early  and 
late  results.  Eur  Heart  J  1988;9(Suppl  E):143-7.
11. Pereira  JJ,  Balaban  K,  Lauer  MS,  Lytle  B,  Thomas  JD, 
Garcia MJ. Aortic valve replacement in patients with mild or 
moderate aortic stenosis and coronary bypass surgery. Am J 
Med  2005;118:735-42.
12. Shahian  DM,  O'Brien  SM,  Filardo  G,  et  al.  The  Society  of 
Thoracic  Surgeons  2008  cardiac  surgery  risk  models:  part 
3--valve  plus  coronary  artery  bypass  grafting  surgery.  Ann 
Thorac  Surg  2009;88:S43-62.
13. Morell  VO,  Daggett  WM,  Pezzella  AT,  Moran  JM,  Bitran 
D.  Aortic  stenosis  in  the  elderly:  result  of  aortic  valve 
replacement.  J  Cardiovasc  Surg  (Torino)  1996;37:33-5.
14. Kirklin JW, Kouchoukos NT. Aortic valve replacement with-
out  myocardial  revascularization.  Circulation  1981;63:252-3.
15. Miller  DC,  Stinson  EB,  Oyer  PE,  Rossiter  SJ,  Reitz  BA, 
Shumway NE. Surgical implications and results of combined 
aortic  valve  replacement  and  myocardial  revascularization. 
Am  J  Cardiol  1979;43:494-501.
16. Mihaljevic  T,  Nowicki  ER,  Rajeswaran  J,  et  al.  Survival  af-
ter  valve  replacement  for  aortic  stenosis:  implications  for 
decision making. J Thorac Cardiovasc Surg 2008;135:1270-8; 
discussion  8-9.
17. Lester  SJ,  Heilbron  B,  Gin  K,  Dodek  A,  Jue  J.  The  natural 
history  and  rate  of  progression  of  aortic  stenosis.  Chest 
1998;113:1109-14.
18. Hochrein  J,  Lucke  JC,  Harrison  JK,  et  al.  Mortality  and 
need  for  reoperation  in  patients  with  mild-to-moderate 
asymptomatic  aortic  valve  disease  undergoing  coronary  ar-
tery  bypass  graft  alone.  Am  Heart  J  1999;138:791-7.
19. Smith  WT,  Ferguson  TB,  Ryan  T,  Landolfo  CK,  Peterson 
ED.  Should  coronary  artery  bypass  graft  surgery  patients 
with  mild  or  moderate  aortic  stenosis  undergo  concomitant 
aortic  valve  replacement?  A  decision  analysis  approach  to 
the  surgical  dilemma.  J  Am  Coll  Cardiol  2004;44:1241-7.
20. Ahmed  AA,  Graham  AN,  Lovell  D,  O'Kane  HO.  Manage-
ment  of  mild  to  moderate  aortic  valve  disease  during  coro-
nary  artery  bypass  grafting.  Eur  J  Cardiothorac  Surg  2003; 
24:535-9;  discussion  9-40.
21. Kobayashi  KJ,  Williams  JA,  Nwakanma  L,  Gott  VL, 
Baumgartner  WA,  Conte  JV.  Aortic  valve  replacement  and 
concomitant coronary artery bypass: assessing the impact of 
multiple  grafts.  Ann  Thorac  Surg  2007;83:969-78.
22. Elayda  MA,  Hall  RJ,  Reul  RM,  et  al.  Aortic  valve  replace-
ment  in  patients  80  years  and  older.  Operative  risks  and 
long-term  results.  Circulation  1993;88:II11-6.
23. Glower  DD,  White  WD,  Hatton  AC,  et  al.  Determinants  of 
reoperation  after  960  valve  replacements  with  Carpentier- 
Edwards  prostheses.  J  Thorac  Cardiovasc  Surg  1994;107: 
381-92;  discussion  92-3.
24. Medalion  B,  Lytle  BW,  McCarthy  PM,  et  al.  Aortic  valve 
replacement  for  octogenarians:  are  small  valves  bad?  Ann 
Thorac  Surg  1998;66:699-705;  discussion-6.
25. Magovern JA, Pennock JL, Campbell DB, et al. Aortic valve 
replacement and combined aortic valve replacement and cor-
onary  artery  bypass  grafting:  predicting  high  risk  groups.  J 
Am  Coll  Cardiol  1987;9:38-43.
26. Kang DH, Park SJ, Rim JH, et al. Early surgery versus con-
ventional  treatment  in  asymptomatic  very  severe  aortic 
stenosis.  Circulation  2010;121:1502-9.
2 7 . B r o w n  M L ,  P e l l i k k a  P A ,  S c h a f f  H V ,  e t  a l .  The  benefits  of 
early valve replacement in asymptomatic patients with severe 
aortic  stenosis.  J  Thorac  Cardiovasc  Surg  2008;135:308-15.